268280.KS
Miwon Specialty Chemical Co., Ltd. [268280.KS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
268280.KS Stock Summary
Top 268280.KS Correlated Resources
268280.KS
Top 10 Correlated ETFs
268280.KS
Top 10 Correlated Stocks
268280.KS
268280.KS Financial details
Company Rating
Buy
Market Cap
738.24B
Income
80.34B
Revenue
617.21B
Book val./share
75538.62
Cash/share
-
Dividend
2300
Dividend %
1.49%
Employees
474
Optionable
No
Shortable
Yes
Earnings
-
P/E
9.64
Forward P/E
-
PEG
0.71
P/S
1.26
P/B
2.05
P/C
-
P/FCF
-21.07
Quick Ratio
-
Current Ratio
3.46
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
16.02K
EPS next Y
-
EPS next Q
-
EPS this Y
130.5%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
36.26%
Revenue last 5Y
20.59%
Revenue Q/Q
-21.29%
EPS Q/Q
0.74%
-
-
-
-
SMA20
-8.03%
SMA50
-18.8%
SMA100
-23.75%
Inst Own
-
Inst Trans
-
ROA
17%
ROE
23%
ROC
0.23%
Gross Margin
24%
Oper. Margin
15%
Profit Margin
13%
Payout
14%
Shs Outstand
5.01M
Shs Float
1.38M
-
-
-
-
Target Price
-
52W Range
146000.0-225000.0
52W High
-31.33%
52W Low
+5.82%
RSI
32
Rel Volume
2.59
Avg Volume
1.05K
Volume
2.71K
Perf Week
3.34%
Perf Month
-9.65%
Perf Quarter
-22.75%
Perf Half Y
-22.94%
-
-
-
-
Beta
0.193737
-
-
Volatility
2118.91%, 6351.64%
Prev Close
3.34%
Price
154500
Change
3%
268280.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
| Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 40.23K | 69.45K | 72.19K | 72.64K | 103.75K | |
| Net income per share | 3.32K | 6.93K | 7.56K | 6.77K | 15.6K | |
| Operating cash flow per share | 6.37K | 4.15K | 13.16K | 13.74K | 6.34K | |
| Free cash flow per share | 3.06K | -1.11K | 9.45K | 9.73K | -2.57K | |
| Cash per share | 4.38K | 3.56K | 10.97K | 15.61K | 11.82K | |
| Book value per share | 35.77K | 42.46K | 47.63K | 50.98K | 63.76K | |
| Tangible book value per share | 35.34K | 41.99K | 47.21K | 50.61K | 63.43K | |
| Share holders equity per share | 35.77K | 42.46K | 47.63K | 50.98K | 63.76K | |
| Interest debt per share | 310.14 | 2.34K | 3.21K | 2.61K | 5.22K | |
| Market cap | 312.79B | 330.59B | 386.8B | 535.17B | 1044.74B | |
| Enterprise value | 297.88B | 334.08B | 350.45B | 468.42B | 1010.87B | |
| P/E ratio | 18.19 | 9.19 | 9.78 | 15.44 | 13.08 | |
| Price to sales ratio | 1.5 | 0.92 | 1.02 | 1.44 | 1.97 | |
| POCF ratio | 9.49 | 15.35 | 5.62 | 7.6 | 32.2 | |
| PFCF ratio | 19.73 | -57.6 | 7.82 | 10.74 | -79.36 | |
| P/B Ratio | 1.69 | 1.5 | 1.55 | 2.05 | 3.2 | |
| PTB ratio | 1.69 | 1.5 | 1.55 | 2.05 | 3.2 | |
| EV to sales | 1.43 | 0.93 | 0.93 | 1.26 | 1.9 | |
| Enterprise value over EBITDA | 10.63 | 5.66 | 5.37 | 7.5 | 8.26 | |
| EV to operating cash flow | 9.04 | 15.51 | 5.09 | 6.66 | 31.16 | |
| EV to free cash flow | 18.79 | -58.21 | 7.09 | 9.4 | -76.79 | |
| Earnings yield | 0.05 | 0.11 | 0.1 | 0.06 | 0.08 | |
| Free cash flow yield | 0.05 | -0.02 | 0.13 | 0.09 | -0.01 | |
| Debt to equity | 0 | 0.05 | 0.04 | 0.03 | 0 | |
| Debt to assets | 0.16 | 0.2 | 0.2 | 0.2 | 0.25 | |
| Net debt to EBITDA | -0.53 | 0.06 | -0.56 | -1.07 | -0.28 | |
| Current ratio | 4.99 | 4.94 | 5.06 | 4.94 | 3.02 | |
| Interest coverage | 1.51K | 388.98 | 210.25 | 273.45 | 1.56K | |
| Income quality | 1.92 | 0.6 | 1.74 | 2.03 | 0.41 | |
| Dividend Yield | 0 | 0.01 | 0.02 | 0.02 | 0.01 | |
| Payout ratio | 0 | 0.07 | 0.22 | 0.26 | 0.12 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
| Capex to operating cash flow | -0.52 | -1.27 | -0.28 | -0.29 | -1.41 | |
| Capex to revenue | -0.08 | -0.08 | -0.05 | -0.06 | -0.09 | |
| Capex to depreciation | -2.25 | -1.91 | -1.23 | -1.25 | -2.72 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 51.7K | 81.37K | 90.01K | 88.12K | 149.61K | |
| ROIC | 0.11 | 0.17 | 0.17 | 0.17 | 0.28 | |
| Return on tangible assets | 0.08 | 0.13 | 0.13 | 0.11 | 0.18 | |
| Graham Net | 2.7K | -454.18 | 5.86K | 8.94K | 1.8K | |
| Working capital | 111.48B | 138.19B | 163.94B | 173.4B | 195.51B | |
| Tangible asset value | 183.03B | 217.9B | 247.1B | 259.17B | 324.83B | |
| Net current asset value | 104.5B | 116.97B | 141.8B | 151.41B | 180.92B | |
| Invested capital | 0.01 | 0.05 | 0.07 | 0.05 | 0.08 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 17.29B | 18.51B | 20.07B | 21.16B | 25.68B | |
| Average inventory | 58.1B | 67.34B | 67.67B | 63.72B | 92.16B | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 28.86 | 19.55 | 22.67 | 26.08 | 27.87 | |
| Days of inventory on hand | 112.87 | 87.42 | 85.52 | 78.55 | 111.31 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 12.65 | 18.67 | 16.1 | 13.99 | 13.1 | |
| Inventory turnover | 3.23 | 4.18 | 4.27 | 4.65 | 3.28 | |
| ROE | 0.09 | 0.16 | 0.16 | 0.13 | 0.24 | |
| Capex per share | -3.3K | -5.26K | -3.71K | -4.01K | -8.91K |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
| Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
|---|---|---|---|---|---|---|
| Revenue per share | 28.37K | 28.41K | 32.01K | 35.07K | 27.6K | |
| Net income per share | 5.48K | 3.04K | 3.85K | 4.55K | 4.58K | |
| Operating cash flow per share | 3.92K | 207.79 | -921.22 | 2.44K | 1.69K | |
| Free cash flow per share | 685.22 | -2.4K | -5.05K | 822.56 | -713.88 | |
| Cash per share | 13.58K | 12.07K | 0 | 0 | 0 | |
| Book value per share | 62.03K | 65.12K | 67.58K | 72.33K | 75.54K | |
| Tangible book value per share | 61.68K | 64.78K | 67.58K | 72.33K | 75.54K | |
| Share holders equity per share | 62.03K | 65.12K | 67.58K | 72.33K | 75.54K | |
| Interest debt per share | 4.88K | 5.32K | 484.25 | 946.93 | 1.75K | |
| Market cap | 942.68B | 1095.61B | 995.33B | 1007.86B | 912.59B | |
| Enterprise value | 921.44B | 1061.74B | 995.33B | 1007.86B | 912.59B | |
| P/E ratio | 8.58 | 17.95 | 12.9 | 11.05 | 9.93 | |
| Price to sales ratio | 6.63 | 7.69 | 6.2 | 5.73 | 6.59 | |
| POCF ratio | 47.93 | 1.05K | -215.48 | 82.36 | 107.82 | |
| PFCF ratio | 274.36 | -91.16 | -39.34 | 244.36 | -254.95 | |
| P/B Ratio | 3.03 | 3.36 | 2.94 | 2.78 | 2.41 | |
| PTB ratio | 3.03 | 3.36 | 2.94 | 2.78 | 2.41 | |
| EV to sales | 6.48 | 7.45 | 6.2 | 5.73 | 6.59 | |
| Enterprise value over EBITDA | 22.9 | 42.27 | 31.99 | 26.94 | 23.25 | |
| EV to operating cash flow | 46.85 | 1.02K | -215.48 | 82.36 | 107.82 | |
| EV to free cash flow | 268.18 | -88.34 | -39.34 | 244.36 | -254.95 | |
| Earnings yield | 0.03 | 0.01 | 0.02 | 0.02 | 0.03 | |
| Free cash flow yield | 0 | -0.01 | -0.03 | 0 | 0 | |
| Debt to equity | 0.06 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0.23 | 0.25 | 0.27 | 0.25 | 0.22 | |
| Net debt to EBITDA | -0.53 | -1.35 | 0 | 0 | 0 | |
| Current ratio | 4.43 | 3.02 | 2.76 | 3 | 3.46 | |
| Interest coverage | 2.05K | 1.4K | 8.89 | 5.84 | 2.43 | |
| Income quality | 0.72 | 0.07 | -0.24 | 0.54 | 0.37 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0.13 | 0 | 0 | 0 | 0.2 | |
| Sales general and administrative to revenue | 0 | 0 | 0.09 | 0.07 | 0.09 | |
| Research and developement to revenue | 0.01 | 0.01 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.83 | -12.53 | 4.48 | -0.66 | -1.42 | |
| Capex to revenue | -0.11 | -0.09 | -0.13 | -0.05 | -0.09 | |
| Capex to depreciation | -3.82 | -3.16 | -4.65 | -1.51 | -2.33 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 87.42K | 66.78K | 76.48K | 86.04K | 88.25K | |
| ROIC | 0.09 | 0.06 | 0.06 | 0.07 | 0.05 | |
| Return on tangible assets | 0.07 | 0.03 | 0.04 | 0.05 | 0.05 | |
| Graham Net | 3.59K | 1.84K | -25.15K | -24.19K | -21.04K | |
| Working capital | 206.51B | 195.51B | 193.23B | 208.67B | 216.84B | |
| Tangible asset value | 309.29B | 324.83B | 0 | 0 | 0 | |
| Net current asset value | 172.41B | 180.92B | 176.72B | 191.74B | 199.32B | |
| Invested capital | 0.08 | 0.08 | 0 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 23.19 | 25.38 | 0 | 0 | 0 | |
| Days of inventory on hand | 78.44 | 101.36 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 3.88 | 3.55 | 0 | 0 | 0 | |
| Inventory turnover | 1.15 | 0.89 | 0 | 0 | 0 | |
| ROE | 0.09 | 0.05 | 0.06 | 0.06 | 0.06 | |
| Capex per share | -3.24K | -2.6K | -4.12K | -1.62K | -2.4K |
268280.KS Frequently Asked Questions
What is Miwon Specialty Chemical Co., Ltd. stock symbol ?
Miwon Specialty Chemical Co., Ltd. is a US stock and trading under the symbol 268280.KS
What is Miwon Specialty Chemical Co., Ltd. stock quote today ?
Miwon Specialty Chemical Co., Ltd. stock price is $154500 today.
Is Miwon Specialty Chemical Co., Ltd. stock public?
Yes, Miwon Specialty Chemical Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 1.05K
- Market Capitalization 738.24B
- Employee 474
- Headquarters Yongin-Si,US
- IPO Date 2017-05-22
-
Website
https://www.miramer.com 
Miwon Specialty Chemical Co., Ltd. engages in the production and supply of basic raw materials for UV/EB curing systems in Korea and internationally. The company's product line includes acrylate and methacrylate monomers, oligomers, photoinitiators, and other related fine chemicals. Its products are used in wood, metal, plastic, nail art, printing ink, adhesive, electronic, optical film, and CD/DVD/Bluray applications. The company was founded in 1959 is headquartered in Yongin, South Korea.
